SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-013506
Filing Date
2023-02-27
Accepted
2023-02-27 21:47:47
Documents
2
Period of Report
2023-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1538
2 EX-24 DOCUMENT attachment1.htm EX-24 2172
  Complete submission text file 0001209191-23-013506.txt   5120
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMUNIX PHARMACEUTICALS, INC. 2 TOWER PLACE, #1100 SOUTH SAN FRANCISCO CA 94080
Business Address
Derynck Mika K (Reporting) CIK: 0001865125 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39247 | Film No.: 23678099